Clinical Trials
5 trialsNCT04711824 2025-12-23
SOLARA
Hoosier Cancer Research Network
Phase 1/2 Recruiting
NCT02338037 2024-03-19
Neuropharmacokinetics of Eribulin Mesylate in Treating Patients With Primary or Metastatic Brain Tumors
City of Hope Medical Center
Phase EARLY_PHASE1 Completed
NCT03613181 2023-04-24
ANGLeD
Angiochem Inc
Phase 3 Unknown
NCT02581839 2020-07-30
Treatment of Brain Metastases From Breast Cancer With Eribulin Mesylate
Case Comprehensive Cancer Center
Phase 2 Completed
NCT03637868 2020-05-06
ERIBRAIN
Institut Paoli-Calmettes
Phase 2 Withdrawn